West Nile Virus

NIH Awards Company $3 Million to Develop Vaccine

Published in Vaccine Weekly, August 16th, 2000

The U.S. National Institutes of Health has awarded a Massachusetts biotechnology firm $3 million to try to create a vaccine for the West Nile virus, which killed seven people in the New York City area last year.

The August 2, 2000, announcement came as several Northeastern states were trying to educate the public about the disease and kill mosquitoes that carry it. OraVax Inc. plans to develop the West Nile vaccine using a proven 60-year-old yellow fever vaccine.

"This is a live viral vaccine like one for measles or mumps or polio," said Thomas Monath, OraVax. "It will cause a very mild infection with no symptoms and leave the person immunized...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-08-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry